4-butyrolactone has been researched along with naloxone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cott, J; Engel, J | 1 |
| Persson, SA | 1 |
| Cleary, J; McIntire, KD; Weinfurter, S | 1 |
| Kummer, P; Stock, G | 1 |
| Bearden, LJ; Snead, OC | 1 |
| McMillen, BA | 1 |
| Aono, T; Irahara, M; Kaji, H; Saito, S; Shitsukawa, K | 1 |
7 other study(ies) available for 4-butyrolactone and naloxone
| Article | Year |
|---|---|
Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine: evidence for both pre- and post-synaptic inhibition of catecholamine systems.
Topics: 4-Butyrolactone; Aminobutyrates; Aminooxyacetic Acid; Animals; Apomorphine; Brain; Clonidine; Corpus Striatum; Dextroamphetamine; Diencephalon; Dose-Response Relationship, Drug; Female; gamma-Aminobutyric Acid; Limbic System; Methyltyrosines; Mice; Morphine; Motor Activity; Naloxone; Norepinephrine; Reserpine; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 1977 |
Effect of morphine on the accumulation of DOPA after decarboxylase inhibition in the rat.
Topics: 4-Butyrolactone; Animals; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; DNA; Haloperidol; Male; Morphine; Naloxone; Rats; Receptors, Drug; Reserpine; Time Factors | 1979 |
Gamma-butyrolactone's discriminability and effect on low rates of lever pressing by rats: alone and in combination with D-amphetamine and naloxone.
Topics: 4-Butyrolactone; Animals; Chlordiazepoxide; Conditioning, Operant; Dextroamphetamine; Discrimination, Psychological; Dose-Response Relationship, Drug; Furans; Male; Naloxone; Rats; Rats, Inbred Strains | 1988 |
Long-term application of haloperidol: effects on dopamine and acetylcholine receptors.
Topics: 4-Butyrolactone; Animals; Benztropine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Drug Interactions; Haloperidol; Male; Naloxone; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Dopamine; Time Factors | 1981 |
Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate.
Topics: 4-Butyrolactone; Animals; Behavior, Animal; Catalepsy; Corpus Striatum; Dopamine; Electroencephalography; Epinephrine; Furans; Humans; Male; Naloxone; Naltrexone; Rats | 1980 |
On the mechanism of morphine action on rat striatal dopamine metabolsim.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Apomorphine; Corpus Striatum; Dopamine; Female; Haloperidol; In Vitro Techniques; Morphine; Naloxone; Rats | 1980 |
The endogenous feeding suppressant, 2-buten-4-olide, impairs the pulsatile secretion of luteinizing hormone through endogenous opioid peptides.
Topics: 4-Butyrolactone; Animals; Appetite Depressants; Female; Furans; Luteinizing Hormone; Naloxone; Periodicity; Pro-Opiomelanocortin; Rats; Rats, Wistar; RNA, Messenger | 1998 |